A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
Clinical trial NCT04591626 · COMPLETED
Trial details
- NCT number
- NCT04591626
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2022-04-28
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.